Status:
COMPLETED
Validation of the New HAG-B19 Scale for Measuring Lean and Fat Body Masse
Lead Sponsor:
Prof. Claude Pichard
Conditions:
Body Composition
Eligibility:
All Genders
20-60 years
Brief Summary
Body composition measurement is an important tool for assessing the physical condition of sick or healthy people, as well as for monitoring changes in body composition and physical performance during ...
Detailed Description
This is an observational, prospective, cross-sectional study to evaluate the accuracy and precision of the new HAG-B19 in healthy Western adults. A stratified sampling method is used to recruit a hete...
Eligibility Criteria
Inclusion
- Healthy Caucasians/Hispanics adults who signed the informed consent form (healthy defined as no chronic disease, no hospitalisation for the last 6 months, no physical disability)
Exclusion
- BMI \<18.5 or ≥ 30 kg/m2
- No informed consent form signed
- Inability to understand the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
- Medication impacting fluid and electrolyte balance (diuretics or calcium channel blocker)
- Moderate to intense level physical activity 2-3 h before measurement
- Pregnancy
Key Trial Info
Start Date :
September 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 25 2021
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04504799
Start Date
September 3 2020
End Date
February 25 2021
Last Update
August 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospital
Geneva, Geneva 14, Switzerland, 1211